【摘要】 目的 分析对慢性阻塞性肺疾病(慢阻肺)稳定期患者施以呼吸慢病全流程连续诊疗服务模式的可行性。方法 60例慢阻肺稳定期患者,以治疗方法不同分为对照组和试验组,每组30例。对照组采用常规治疗,试验组在对照组基础上采用呼吸慢病全流程连续诊疗服务模式。对比两组临床指标(症状缓解时间、住院时间、1年内住院次数)、肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积占预计值的百分比(FEV1%)]、生活质量[圣乔治呼吸问卷(SGRQ)评分]、日常生活活动能力(Barthel指数)、活动能力[6 min步行试验距离(6MWD)]、依从性。结果 试验组症状缓解时间(3.45±0.56)d、住院时间(7.48±1.56)d较对照组的(5.18±0.43)、(10.56±1.45)d短, 1年内住院次数(1.10±0.25)次较对照组的(3.22±0.37)次少(P<0.05)。干预后,试验组FVC(2.48±0.22)L、FEV1%(56.64±2.14)%较对照组的(2.22±0.18)L、(53.16±2.26)%高(P<0.05)。干预后,试验组SGRQ中疾病影响、活动能力、呼吸症状评分及总分均较对照组低(P<0.05)。干预后,试验组Barthel指数(81.45±9.36)分较对照组的(72.67±9.30)分高, 6MWD(398.90±42.42)m较对照组的(353.90±33.83)m长(P<0.05)。试验组总依从率100.00%较对照组的80.00%高(P<0.05)。结论 对慢阻肺稳定期患者施以呼吸慢病全流程连续诊疗服务模式可行性较好,可优化临床指标,利于肺功能、生活质量、日常生活活动能力和运动能力改善,依从性较高,值得推广。更多还原

【Abstract】 Objective To analyze the feasibility of implementing a comprehensive continuous diagnosis and treatment service model for chronic respiratory diseases in patients with stable chronic obstructive pulmonary disease(COPD). Methods A total of 60 patients with stable COPD were divided into a control group and an experimental group by different treatment methods, each comprising 30 cases. The control group received conventional treatment, and the experimental group received the comprehensive continuous diagnosis and treatment service model for respiratory chronic diseases. Comparison was made on clinical indicators(symptom relief time, hospitalization duration, hospitalization frequency within 1 year), pulmonary function indicators [forced vital capacity(FVC), forced expiratory volume in one second as a percentage of the predicted value(FEV1%)], quality of life [St. George’s Respiratory Questionnaire(SGRQ) score], daily living ability(Barthel index), activity ability [6-min walk distance(6 MWD)], and compliance between the two groups. Results In the experimental group, the symptom relief time was(3.45±0.56) d and the hospitalization duration was(7.48±1.56) d, which were shorter than the control group [(5.18±0.43) and(10.56±1.45) d]; the hospitalization frequency within 1 year(1.10± 0.25) times was less than the control group’s(3.22±0.37) times(P<0.05). After the intervention, the experimental group had higher FVC(2.48±0.22) L and FEV1%(56.64±2.14) % compared to the control group [(2.22± 0.18) L and(53.16±2.26) %](P<0.05). After the intervention, the SGRQ scores for disease impact, functional capacity, respiratory symptoms, and total score in the intervention group were lower than those in the control group(P<0.05). After the intervention, the experimental group had a higher Barthel index(81.45±9.36) points than the control group’s(72.67±9.30) points, and a longer 6 MWD(398.90±42.42) m than the control group’s(353.90±33.83) m(P<0.05). The total compliance rate 100.00% of the experimental group was higher than the control group’s 80.00%(P<0.05). Conclusion The comprehensive continuous diagnosis and treatment service model for respiratory chronic diseases is feasible for patients with stable chronic obstructive pulmonary disease, as it optimizes clinical indicators, facilitate the improvement of pulmonary function, quality of life, daily living ability, and exercise capacity, with high compliance, making it worthy of promotion.更多还原